All entries for: Terns Pharmaceuticals, Inc.

March 30, 2026

Terns Pharmaceuticals, Inc.

Neutral Outlook

Foster City, CA
51-200 employees

Since adoption of the IRA, the Trump Administration has taken a number of actions to reduce the costs of pharmaceutical products, including through the issuance of Executive Orders. For example, a number of pharmaceutical companies have entered into agreements with the Administration to provide for lower prices on certain pharmaceuticals in response to an Executive Order relating to the potential imposition of most favored nation pricing in the United States.

March 30, 2026

Terns Pharmaceuticals, Inc.

Neutral Outlook

Foster City, CA
51-200 employees

Regulatory guidance under the IRA, the OBBBA, and other tax-related legislation is and continues to be forthcoming, and such guidance could ultimately increase or lessen the impact of these laws on our business and financial condition. In addition, it is uncertain if and to what extent various states will conform to changes to federal tax legislation.

Disease Area: Metabolic Diseases, Oncology
Drug Type: Small Molecule
Scroll to Top